期刊文献+

武汉地区人群中CD14单核细胞受体基因启动子区多态性与冠心病的关系 被引量:2

Polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for coronary heart disease in a Wuhan population
下载PDF
导出
摘要 目的探讨中国武汉地区汉族人群中CD14基因启动子区C(-260)→T多态性与冠心病的关系。方法应用聚合酶链反应限制片段长度多态性(PCR-RFLP)分析技术检测218例冠心病患者(冠心病组)和230例正常人(对照组)CD14基因C(-260)→T多态性。结果CC型、TC型及TT型频率在冠心病组中分别为22%、26%、52%,对照组分别为51%、17%、31%,冠心病组TT型明显高于对照组(52%vs31%)。T等位基因频率在冠心病组与对照组中分别为65%和49%。所有基因型及等位基因频数分布符合Hardy-Weinberg平衡。结论CD14基因C(-260)→T点突变多态性与冠心病发病密切相关,CD14基因启动子区突变纯合子可能是引起冠心病的一个重要的遗传性危险因素。 Obejective To explore whether the C( -260)→T polymorphism of the CD14 gene constitutes a risk factor for coronary heart disease (CHD) in a Wuhan population.Methods With employing a case-control study design, the CD14 C( -260)→T polymorphism was evaluated in 218 newly diagnosed inpatients with CHD (cases), and 230 healthy subjects (controls). CD14 genotype was determined by polymerase chain reaction PCR-RFLP Hae Ⅲ digestion. Results In CHD patients, the genotype frequencies were as follows: CC 22% ,TC 26% and TT 52%, and in controls, they were 51%, 17% and 31% respectively. The frequency of the TT genotype was significantly higher in the cases than in controls (52% vs 31% ). The frequency of the T allele (absence of the cutting site) was 65% in cases and 49% in controls. All observed genotype frequencies were in Hardy-Weinberg equilibrium. Conclusions In the patients examined in this study, the C( - 260)→T polymorphism of the CD14 gene is related to CHD, and in addition to the well-established risk factors, the genetically determined reaction of monocytes/macrophages to infection stimuli may play an important role in the
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2006年第3期184-186,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 国家自然科学基金海外青年学者合作基金(30128021)
关键词 冠状动脉疾病 多态现象(遗传学) 聚舍酶链反应 单核细胞 危险因素 流行病学 coronary disease polymorphism (genetics) polymerase chain reaction monocytes risk factors epidemiology
  • 相关文献

参考文献9

  • 1Ross R. Atherosclerosis-an inflammatroy disease[J ]. New Engl J Med, 1999,340:115-126.
  • 2Agema WRP, Jukema JW, de Maat MPM, et al. Pharmacogenetics of the CD14 endotoxin receptor polymorphism and progression of coronary atherosclerosis [J]. Thromb Haemost, 2004,91 : 986-990.
  • 3Kondo T, Ohno M, Shimokata K, et al. CD14 promoter polymorphismis associated with acute myocardial infarction resulting from insignificant coronary artery stenosis[J]. Heart,2003,89:931-932.
  • 4Unkelbach K, Gardemann A, Kostrzewa M, et al. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile[J]. Arterioscler Thromb Vasc Biol, 1999,19:932-938.
  • 5Hubacek JA, Tit' ha J, Skodova Z, et al. C( - 260)T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction [ J ]. Circulation, 1999,99: 3218-3220.
  • 6Shimada K, Watanabe Y, Mokuno H, et al. Common polymorphism is the promoter of the CD14 monocyte receptor gene associated with acute myocardial infarction in Japanese men[J]. Am J Cardiol, 2000, 86:682-684.
  • 7Zee RY, Lindpaintner K, Struk B, et al. A prospective evaluation of the CD14 C( - 260)T gene polymorphism and the risk of myocardial infarction[ J ]. Atherosclerosis, 2001,154: 699-702.
  • 8Koenig W,Khuseyinova N,Hoffmann MM, et al. CD14 C( - 260)→T polymorphism, plasma levels of the soluble endotoxin receptor CD14,their association with chronic infections and risk of stable coronary artery disease [ J ]. JACC, 2002,40: 34-42.
  • 9Arroyo-Espliguero R, Avanzas P, Jeffery S, et al. CD14 and toll-like receptor 4: a link between infection and acute coronary events [ J] ?Heart, 2004,90: 983-988.

同被引文献20

  • 1Hohda S, Kimura A, Sasaoka T, et al.As sociation study of CD14 polymorphism with myocardial infarction in a Japanese population [J]. Jpn Heart J, 2003, 44(5) : 613.
  • 2Jaros lay A, Hubacek Jan, Pit ha, et al. C(-260)T Polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction[J]. Circulation, 1999, 99(28) : 3218.
  • 3Roberts W I, Mouhon L, Law TC, et al. Evaluation of nine automated high-sens itivity C-reactive Protein methods : implications for clinical and epidemiological applicatlons[J]. Clin Chcm, 2001,47(3) : 418.
  • 4Haverkate F, Thompson SG, Pyke SDM, et al. Production of Creactive protein and risk of coronary events in stable and unstable angina [J]. Lancet, 1997, 349:462.
  • 5Zee RY, Lindpaintner K, Stink B, et al. A prospective evaluation of the CD14 C (-260)T gene polymorphism and the risk of myocanlial infarction[J]. Atheroscleros is, 2001, 154:699.
  • 6Arroyo-Espliguem R, El-Shamouby K, Vazquez-Rey E, et al. CD14 C(-260) T promoter polymorphism and prevalence of acute coronary syndromes[J]. Int J Cardiol, 2005, 98:307.
  • 7Koenig W, Khuseyinova N, Hoffmann MM, et al. CD14 C(-260) T polymorphism, plasma levels of the soluble endotoxin receptor CDl4, their association with chronic infections and risk of stable coronary heart disease[J]. J Am Coll Cardiol, 2002, 40:34.
  • 8Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention[J]. Circulation, 2003, 107: 363.
  • 9Esther Bemardo, Dominick J, Celia R, et al. Influence tithe CD14 C-260T promoter polymorphism on Creactive Protein levels in patients with coronary heart disease [J]. Am J Cardiol, 2006, 98:1182.
  • 10Roberts W I, Moulton L, Law T c, et al. Evaluation of nine automated high-sensitivity C-reactive Protein methods: implications for clinical and epidemiological applications [J]. Clin Chem, 2001, 47(3):418.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部